Berthold, Frank
Ernst, Angela
Hero, Barbara
Klingebiel, Thomas
Kremens, Bernhard
Schilling, Freimut H.
Simon, Thorsten
Funding for this research was provided by:
Deutsche Krebshilfe (70-2290-Be)
Deutsche Kinderkrebsstiftung (96.06 and 99.03)
Article History
Received: 10 March 2018
Revised: 1 June 2018
Accepted: 14 June 2018
First Online: 11 July 2018
Change Date: 24 September 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: The authors declare no competing interests.
: Not applicable. There are no publicly archived datasets on patient’s characteristics and outcome.
: The trial NB97 (EU-20661 and NCT00526318) has been conducted according to the principles of the Guidelines for Good Clinical Practice (ICH-GCP) and in accordance with Declaration of the Helsinki of the World Medical Association. The protocol was approved by the ethics committee of the University of Cologne (9764/1997) as well as by the cooperating institutions. Written informed consent was obtained at the local site from the parents or legal guardians and was a prerequisite to register in the trial. The patients signed –if appropriate- age-adapted assent forms
: Not applicable. No individual person’s data are used.